XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://biotechstocks.com/new-technology-at-the-nicklaus-childrens-hospital/20%Monthly2017-01-31 20:51
https://biotechstocks.com/mannkind-corporation-nasdaqmnkd-to-host-an-investor-update/20%Monthly2017-01-31 13:38
https://biotechstocks.com/calithera-biosciences-inc-nasdaqcala-and-incyte-corporation-nasdaqincy-report-global-collaboration/20%Monthly2017-01-31 13:35
https://biotechstocks.com/medical-implants-may-have-a-resistant-coating-to-prevent-rejection/20%Monthly2017-01-30 20:50
https://biotechstocks.com/adxs-study-in-metastatic-cervical-cancer/20%Monthly2017-01-30 13:45
https://biotechstocks.com/lsd-could-be-a-bipolar-disorder-treatment/20%Monthly2017-01-27 20:33
https://biotechstocks.com/bone-fractures-could-be-treated-by-new-stem-cell-method/20%Monthly2017-01-26 21:00
https://biotechstocks.com/researchers-sequence-poisonous-mushrooms-to-destroy-diseases/20%Monthly2017-01-25 20:17
https://biotechstocks.com/researchers-on-the-verge-of-new-cancer-treatment/20%Monthly2017-01-24 20:54
https://biotechstocks.com/aptose-biosciences-inc-nasdaqapto-prioritizes-advancement-of-cg806-flt3btk-inhibitor/20%Monthly2017-01-24 12:34
https://biotechstocks.com/infinity-pharmaceuticals-inc-nasdaqinfi-showcase-phase-i-clinical-data-on-ipi-549/20%Monthly2017-01-24 12:27
https://biotechstocks.com/researchers-may-have-found-new-asd-treatment/20%Monthly2017-01-23 20:28
https://biotechstocks.com/rexahn-pharmaceuticals-inc-nysemktrnn-releases-update-on-phase-iia-clinical-study-of-rx-3117/20%Monthly2017-01-23 12:50
https://biotechstocks.com/ariad-pharmaceuticals-inc-nasdaqaria-under-enquiry-for-investors-over-takeover/20%Monthly2017-01-23 12:47
https://biotechstocks.com/new-computational-tool-to-recommend-cancer-treatments/20%Monthly2017-01-20 20:30
https://biotechstocks.com/amrn-form-8-k-7/20%Monthly2017-01-20 14:20
https://biotechstocks.com/celg-announced-a-merger-set-to-establish-immunotherapeutic-collaboration/20%Monthly2017-01-20 14:18
https://biotechstocks.com/mast-therapeutics-inc-nysemktmstx-merges-with-savara-to-build-a-team-in-lungheart-inhalation-therapies/20%Monthly2017-01-20 12:15
https://biotechstocks.com/ariad-pharmaceuticals-inc-nasdaqaria-closes-marginally-in-green/20%Monthly2017-01-20 12:13
https://biotechstocks.com/researchers-are-one-step-closer-to-a-cure-for-hiv/20%Monthly2017-01-19 20:59
https://biotechstocks.com/cytx-form-8-k/20%Monthly2017-01-19 13:54
https://biotechstocks.com/cytx-acquire-proprietary-nanoparticle-development-platform/20%Monthly2017-01-19 13:53
https://biotechstocks.com/why-mast-therapeutics-inc-nysemktmstxs-merger-with-savara-inc-is-a-strategic-move/20%Monthly2017-01-19 10:10
https://biotechstocks.com/why-gilead-sciences-inc-nasdaqgild-crashed-2016-despite-strong-drugs-in-market/20%Monthly2017-01-19 10:06
https://biotechstocks.com/cure-for-diabetes-at-our-fingertips/20%Monthly2017-01-18 20:55
https://biotechstocks.com/why-bellerophon-therapeutics-inc-nasdaqblph-is-in-focus/20%Monthly2017-01-18 15:07
https://biotechstocks.com/what-is-weighing-on-gilead-sciences-inc-nasdaqgild/20%Monthly2017-01-18 15:05
https://biotechstocks.com/bntc-secures-orphan-drug-designation/20%Monthly2017-01-18 14:17
https://biotechstocks.com/dr-peter-john-wormald-on-ampliphi-biosciences-corp-nysemktaphb-phase-1-report-of-ab-sa01-2/20%Monthly2017-01-17 06:54
https://biotechstocks.com/ceo-john-milligan-vision-for-gilead-sciences-inc-nasdaqgild-2/20%Monthly2017-01-17 06:51
https://biotechstocks.com/dr-peter-john-wormald-on-ampliphi-biosciences-corp-nysemktaphb-phase-1-report-of-ab-sa01/20%Monthly2017-01-16 13:25
https://biotechstocks.com/ceo-john-milligan-vision-for-gilead-sciences-inc-nasdaqgild/20%Monthly2017-01-16 13:22
https://biotechstocks.com/many-conditions-being-treated-with-light-activated-medications/20%Monthly2017-01-13 20:26
https://biotechstocks.com/can-celsion-corporation-nasdaqclsn-meet-nasdaq-listing-requirements/20%Monthly2017-01-13 12:18
https://biotechstocks.com/what-the-future-holds-for-gilead-sciences-inc-nasdaqgild/20%Monthly2017-01-13 12:13
https://biotechstocks.com/researchers-found-genome-viruses-important-for-the-brain/20%Monthly2017-01-12 20:56
https://biotechstocks.com/mast-therapeutics-inc-nysemktmstx-and-savara-finalizes-merger-deal/20%Monthly2017-01-12 12:19
https://biotechstocks.com/merrimack-pharmaceuticals-inc-nasdaqmack-falls-for-1-billion-oncology-offer/20%Monthly2017-01-12 12:16
https://biotechstocks.com/market-future-for-depression-therapy-and-anxiety-disorders/20%Monthly2017-01-11 20:26
https://biotechstocks.com/takeda-pharmaceutical-co-ltd-adrotcmktstkpyy-will-part-with-5-2-billion-in-its-acquisition-of-ariad-pharmaceuticals-inc-nasdaqaria/20%Monthly2017-01-11 12:38
https://biotechstocks.com/what-mast-therapeutics-inc-nysemktmstx-and-savara-inc-merger-means/20%Monthly2017-01-11 12:31
https://biotechstocks.com/potential-new-therapy-for-alzheimers-patients/20%Monthly2017-01-10 20:24
https://biotechstocks.com/mannkind-corporation-nasdaqmnkds-executive-changes-plunges-it-on-market/20%Monthly2017-01-10 13:40
https://biotechstocks.com/harwood-feffer-llp-to-investigate-ariad-pharmaceuticals-inc-nasdaqaria-takeda-deal/20%Monthly2017-01-10 13:36
https://biotechstocks.com/researchers-reveal-findings-from-primary-sclerosing-cholangitis-study/20%Monthly2017-01-09 20:43
https://biotechstocks.com/adxs-form-8-k-3/20%Monthly2017-01-09 14:52
https://biotechstocks.com/protalix-biotherapeutics-inc-nysemktplx-releases-interim-data-from-phase-2-clinical-trials-targeting-cystic-fibrosis/20%Monthly2017-01-09 08:11
https://biotechstocks.com/natural-cure-for-prostate-enlargement-and-cancer/20%Monthly2017-01-06 20:53
https://biotechstocks.com/mannkind-corporation-nasdaqmnkd-receives-1-million-as-milestone-payment/20%Monthly2017-01-06 12:44
https://biotechstocks.com/the-5-stocks-which-are-loved-by-insiders-the-most-currently-with-verifone-systems-inc-nysepay-among-them/20%Monthly2017-01-06 12:24
https://biotechstocks.com/fast-track-for-peanut-allergy-vaccine/20%Monthly2017-01-05 20:59
https://biotechstocks.com/xxii-fda-provides-positive-and-encouraging-feedback-for-very-low-mrtpa-filings/20%Monthly2017-01-05 14:37
https://biotechstocks.com/alxn-form-8-k-6/20%Monthly2017-01-05 14:30
https://biotechstocks.com/mdvx-names-ed-valdez-quality-manager/20%Monthly2017-01-05 14:27
https://biotechstocks.com/kowa-pharmaceuticals-america-inc-inters-into-an-exclusive-agreement-with-cymabay-therapeutics-inc-nasdaqcbay-to-develop-and-commercialize-gout-compound/20%Monthly2017-01-05 11:50
https://biotechstocks.com/cel-sci-corporation-nysemktcvm-rises-despite-long-silence/20%Monthly2017-01-05 06:11
https://biotechstocks.com/research-shows-adding-a-second-medication-may-benefit-patients-with-type-2-diabetes/20%Monthly2017-01-04 20:43
https://biotechstocks.com/what-to-expect-for-insys-therapeutics-inc-nasdaqinsy-in-coming-days/20%Monthly2017-01-04 06:30
https://biotechstocks.com/north-american-cannabis-holdings-inc-otcmktsusmj-releases-comprehensive-shareholder-update-with-puration-inc-otcmktspura/20%Monthly2017-01-04 06:21
https://biotechstocks.com/cancer-treatment-gives-hope-in-fighting-brain-tumors/20%Monthly2017-01-03 20:41
https://biotechstocks.com/kite-submits-investigational-new-drug-ind-application/20%Monthly2017-01-03 14:43
https://biotechstocks.com/mdvx-corporation-receives-sgs-certification-for-its-denervextm-system/20%Monthly2017-01-03 14:29